Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 2674

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 1
Chunk 2674
---
management team has limited experience managing a public company.

Most
of the members of our management team have limited to no experience managing a publicly traded company, interacting with public company
investors and complying with the increasingly complex laws pertaining to public companies. Our management team has not worked together
at prior companies that were publicly traded. Our management team may not successfully or efficiently manage their new roles and responsibilities.
Our transition to being a public company has subjected us to significant regulatory oversight and reporting obligations under the federal
securities laws and the continuous scrutiny of securities analysts and investors. These new obligations and constituents will require
significant attention from our senior management and could divert their attention away from the day-to-day management of our business,
which could have a material adverse effect on our business, financial condition and results of operations.

The
Company’s Third Amended and Restated Certificate of Incorporation requires, to the fullest extent permitted by law, that derivative
actions brought in our name, as applicable, against their respective directors, officers, other employees or stockholders for breach
of fiduciary duty and other similar actions may be brought only in the Court of Chancery in the State of Delaware, which may have the
effect of discouraging lawsuits against our directors, officers, other employees or stockholders, as applicable.

125

Pursuant
to the Company’s Third Amended and Restated Certificate of Incorporation (“the “Amended Certificate”), unless
we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive
forum for any state law claims for: (i) any derivative action or proceeding brought on our behalf; (ii) any action asserting a claim
of breach of a fiduciary duty or other wrongdoing by any of our directors, officers, employees or agents to us or our stockholders; (iii)
any action asserting a claim against us arising pursuant to any provision of the General Corporation Law of the State of Delaware, the
Amended Certificate and the Company’s bylaws; (iv) any action to interpret, apply, enforce or determine the validity of the Amended
Certificate and the Company’s bylaws; or (v) any action asserting a claim governed by the internal affairs doctrine, in each case
subject to the Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein, or the Delaware
forum provision. This exclusive forum provision will not apply to any causes of action arising under the Securities Act